BriaCell Therapeutics Corp. Stock Nasdaq
Equities
BCTX
CA1079301091
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.17 USD | -3.12% | +7.43% | -62.91% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.12M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.58
x | P/E ratio 2025 * |
-1.76
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.73% |
1 day | -3.13% | ||
1 week | +7.43% | ||
Current month | -24.13% | ||
1 month | -14.57% | ||
3 months | -45.75% | ||
6 months | -50.00% | ||
Current year | -62.91% |
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 16-10-31 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 16-01-31 |
Chief Tech/Sci/R&D Officer | 53 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 16-05-09 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-08-30 |
Rebecca Taub
BRD | Director/Board Member | 71 | 18-03-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.17 | -3.13% | 36,051 |
24-04-25 | 2.24 | +2.28% | 29,085 |
24-04-24 | 2.19 | -5.60% | 22,628 |
24-04-23 | 2.32 | +5.45% | 36,120 |
24-04-22 | 2.2 | +8.91% | 17,379 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- BCT Stock
- BCTX Stock